Lorcainide
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| N-(4-chlorophenyl)-N-(1-isopropylpiperidin-4-yl)-2-phenylacetamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Pharmacokinetic data | |
| Protein binding | 78 |
| Half-life | 14.3 +/-3.7 |
| Identifiers | |
| CAS number | 59729-31-6 |
| ATC code | C01BC07 |
| PubChem | CID 42884 |
| ChemSpider | 39116 |
| UNII | KGJ2T0N7IQ |
| KEGG | D08020 |
| ChEMBL | CHEMBL87543 |
| Chemical data | |
| Formula | C22H27ClN2O |
| Mol. mass | 370.915 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Lorcainide is a class 1c antiarrhythmic agent. It was discovered at Janssen Pharmaceutica in 1968.
[edit] References
- Kesteloot H, Stroobandt R., Clinical experience with lorcainide (R 15 889), a new anti-arrhythmic drug, Arch Int Pharmacodyn Ther. 1977 Dec;230(2):225-34.
- Carmeliet E, Janssen PA, Marsboom R, Van Nueten JM, Xhonneux R., Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide, Arch Int Pharmacodyn Ther. 1978 Jan;231(1):104-30.
|
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |

